Thompson R Houston, Kaag Matt, Vickers Andrew, Kundu Shilajit, Bernstein Melanie, Lowrance William, Galvin David, Dalbagni Guido, Touijer Karim, Russo Paul
Urology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
J Urol. 2009 Mar;181(3):993-7. doi: 10.1016/j.juro.2008.11.017. Epub 2009 Jan 16.
The use of partial nephrectomy for renal cortical tumors appears unacceptably low in the United States according to population based data. We examined the use of partial nephrectomy at our tertiary care facility in the contemporary era.
Using our prospectively maintained nephrectomy database we identified 1,533 patients who were treated for a sporadic and localized renal cortical tumor between 2000 and 2007. Patients with bilateral disease or solitary kidneys were excluded from study and elective operation required an estimated glomerular filtration rate of 45 ml per minute per 1.73 m(2) or greater. Predictors of partial nephrectomy were evaluated using logistic regression models.
Overall 854 (56%) and 679 patients (44%) were treated with partial and radical nephrectomy, respectively. In the 820 patients treated electively for a tumor 4 cm or less the frequency of partial nephrectomy steadily increased from 69% in 2000 to 89% in 2007. In the 365 patients treated electively for a 4 to 7 cm tumor the frequency of partial nephrectomy also steadily increased from 20% in 2000 to 60% in 2007. On multivariate analysis male gender (p = 0.025), later surgery year (p <0.001), younger patient age (p = 0.005), smaller tumor (p <0.001) and open surgery (p <0.001) were significant predictors of partial nephrectomy. American Society of Anesthesiologists score, race and body mass index were not significantly associated with treatment type.
The use of partial nephrectomy is increasing and it is now performed in approximately 90% of patients with T1a tumors at our institution. For reasons that remain unclear certain groups of patients are less likely to be treated with partial nephrectomy.
基于人群的数据显示,在美国,肾皮质肿瘤行部分肾切除术的比例低得令人难以接受。我们研究了当代三级医疗中心部分肾切除术的应用情况。
利用前瞻性维护的肾切除术数据库,我们确定了2000年至2007年间因散发性局限性肾皮质肿瘤接受治疗的1533例患者。双侧病变或单肾患者被排除在研究之外,择期手术要求估计肾小球滤过率为每分钟每1.73平方米45毫升或更高。使用逻辑回归模型评估部分肾切除术的预测因素。
总体而言,分别有854例(56%)和679例患者(44%)接受了部分肾切除术和根治性肾切除术。在820例因肿瘤直径4厘米或更小而接受择期治疗的患者中,部分肾切除术的频率从2000年的69%稳步上升至2007年的89%。在365例因肿瘤直径4至7厘米而接受择期治疗的患者中,部分肾切除术的频率也从2000年的20%稳步上升至2007年的60%。多因素分析显示,男性(p = 0.025)、手术年份较晚(p <0.001)、患者年龄较轻(p = 0.005)、肿瘤较小(p <0.001)和开放手术(p <0.001)是部分肾切除术的显著预测因素。美国麻醉医师协会评分、种族和体重指数与治疗类型无显著相关性。
部分肾切除术的应用正在增加,目前在我们机构中,约90%的T1a期肿瘤患者接受了该手术。由于尚不清楚的原因,某些患者群体接受部分肾切除术的可能性较小。